Dt&C BioGroup

We Make We Create We are Pioneers

Service Scope

Dt&C BioGroup’s One Stop CRO Service Scope

  1. 01

    Analysis

    • Clinical Trial Material Analysis
    • Toxicokinetic Analysis
    • Pharmacokinetic Analysis
    • Protein Characterization
  2. 02
    Pre-clinical trial consultation

    Non-clinical Trial

    • General Toxicity
    • Genotoxicity
    • Local/Immuno-toxicity
    • Reproductive/Developmental Toxicity
    • Pathological Test
  3. 03

    Clinical Trial

    • Regulatory Affairs
    • CIP Development
    • Site/Investigator Identification & Qualification
    • Investigator Meeting
    • Inspection / Audit
    • Data Management
    • Statistical Analysis
    • Clinical Investigation Reporting
    • Monitoring
    • Project Management
    • CRF Development
    • Pharmacovigilance
  4. 04

    Others

    • License In/Out Service
    • Global Partnering
    • License Holding
    • Contract Manufacturing Service
    • SOP Review / Consulting
From discovery to development

One path, two companies

Discovery Period
Dt&CRO
Development Period
Dt&SanoMedics
  1. 01

    Activity Establishment

    Strategic Consulting · Project Management

    • Dt&CRO
  2. 02

    Candidates Selection

    Master Plan Development

    • Dt&CRO
  3. 03

    Manufacturing & Quality Control

    SOP Development · GMP Consultation · Audit & Inspection

    • Dt&CRO
  4. 04

    Safety & Efficacy

    • Dt&CRO
  5. 05

    Phase 1

    • Dt&CRO
    • Dt&SanoMedics
  6. 06

    Phase 2

    • Dt&CRO
    • Dt&SanoMedics
  7. 07

    Phase 3, Medical Devices

    • Dt&SanoMedics
  8. 08

    Real World Data (RWD), Phase IV, RMP, OS

    • Dt&SanoMedics
2000 – 2020

History

2020

  • Signed strategic alliance MOU with Ajou University Hospital
  • Signed strategic alliance MOU with Korean Cancer Study Group for anti-cancer drugs clinical study development
  • Signed Medical device industry promotion and development MOU with Korea University Medicine

2019

  • Signed strategic alliance MOU with Chung-Ang University for new strain of infectious disease response
  • MFDS GLP Certificate
  • Signed strategic alliance with Korea Biotechnology Industry Organization for manpower training

2018

  • Signed co-development agreement with ABL Bio, TRIGR Therapeutics on multiple myeloma
  • Signed strategic alliance with KoNECT for training

2017

  • Signed license agreement with ABL Bio
  • Established Dt&SanoMedics Co., Ltd.
  • Established Dt&CRO Co., Ltd. (Bio-analysis, Non-Clinical Trial Center)

2014

  • Name of company changed to Dt&C Co., Ltd. (Digital Technology & Certification)

2013

  • Designated as a medical device testing organization (MFDS, 201407)

2009

  • Designated by Samsung and LG as testing agency certification

2000

  • Established Digital EMC Co., Ltd.